Ocugen to host webcast on phase 2 trial data for geographic atrophy therapy
Tweet Send to a Friend
Ocugen Inc. (NASDAQ: OCGN) announced it will host a webcast on March 24 at 8 a.m. EDT to discuss Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
